Established under a Research Collaboration Agreement with the U.S. Food and Drug Administration (FDA), the National Medication Safety, Outcomes, and Adherence Program (NMSOAP) is the first medication safety surveillance and monitoring program that links comprehensive longitudinal patient-centric data – acquired in the “voice of the patient” via monthly surveys – with information contained in health records.
By making the patient part of the solution and incorporating the “voice-of-the-patient” into big data analytics, the ultimate goals of the NMSOAP are to:
- Establish and track post-launch evolving patterns of medication safety and health outcomes;
- Identify early warning signs of issues that may either impact medication adherence or signal an important adverse event that can potentially be averted.
The benefits of NMSOAP participation to healthcare providers, pharmacists and health systems include:
- Tracks patterns and reasons for poor adherence and makes this available to the patient’s healthcare team, thereby shortening the time between when a problem is identified and when it is addressed. Increased adherence translates to improved clinical outcomes.
- Provides an early warning system for medication side effects to prevent costly emergency room visits or hospital admissions.
- Increases the collection of data that documents improved clinical outcomes.
- Utilizes patient reported safety and efficacy assessments of prescribed medications as well as enhances medication adherence and persistence.
- Lowers costs due to reductions in ER visits, hospitalizations and other cost factors.
- Brings the ultimate end-user of the healthcare system – the patient – into the process of evaluating the benefits and risks of medications as they are used in the “real world,” making patients an active part of the solution.
Help NMSOAP collect the “voice of the patient” by enrolling patients in your practice.